Schedule 13G ownership disclosure

CTI BIOPHARMA CORP

Security class unavailable · CUSIP: 12648L601

Event date: 2022-06-07

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001273087-22-000076
Form type
SC 13G
Filer
CTI BIOPHARMA CORP
CIK
CIK 891293
Filed
Jun 13, 2022
Reporting period
Jun 07, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub